Search

Your search keyword '"Scott Letendre"' showing total 88 results

Search Constraints

Start Over You searched for: Author "Scott Letendre" Remove constraint Author: "Scott Letendre" Language english Remove constraint Language: english
88 results on '"Scott Letendre"'

Search Results

1. Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection

2. Sex-specific associations between plasma interleukin-6 and depression in persons with and without HIV

3. Subacute myoclonic measles encephalitis – An opportunistic HIV-associated infection

4. Signatures of HIV and Major Depressive Disorder in the Plasma Microbiome

5. Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years

6. Depression in Individuals Coinfected with HIV and HCV Is Associated with Systematic Differences in the Gut Microbiome and Metabolome

7. Reduced Independence in Daily Living Is Associated with the Gut Microbiome in People with HIV and HCV

8. The Relationships between HIV-1 Infection, History of Methamphetamine Use Disorder, and Soluble Biomarkers in Blood and Cerebrospinal Fluid

9. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment

10. European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection

11. Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia

12. HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders

13. Portable lactate analyzer for measuring lactate in cerebrospinal fluid (CSF) and plasma ? method-comparison evaluations

14. (1→3)-β-D-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection?

15. Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR.

16. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).

17. Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.

18. Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence.

19. Evidence of the innate antiviral and neuroprotective properties of progranulin.

20. The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China.

21. Plasma proteomic profiling in HIV-1 infected methamphetamine abusers.

22. Human immunodeficiency virus and the central nervous system

24. Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and Adjuvants

25. Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV

26. HIV influences microtubule associated protein-2: Potential marker of HIV-associated neurocognitive disorders

27. Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood

28. Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume

29. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults

30. Benzodiazepine Use is Associated with an Increased Risk of Neurocognitive Impairment in People Living with HIV

31. Characteristics of Motor Dysfunction in Longstanding Human Immunodeficiency Virus

32. Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder

33. Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment Among HIV-infected Individuals

34. European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements

35. Genome-Wide Association Study of HIV-Associated Neurocognitive Disorder (HAND): a CHARTER Group Study

36. Everyday functional ability in HIV and methamphetamine dependence

37. Higher cystatin C levels are associated with neurocognitive impairment in older HIV+ adults

38. Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation

39. (1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection?

40. Update and New Directions in Therapeutics for Neurological Complications of HIV Infections

41. Persistent CSF but not Plasma HIV RNA, is Associated with Increased Risk of New-onset Moderate-to-Severe Depressive Symptoms; A Prospective Cohort Study

42. Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia

43. Pathogenesis of HIV in the Central Nervous System

44. Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART

45. HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-Associated Neurocognitive Disorders

46. Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease

47. Antiretroviral therapy reduces neurodegeneration in HIV infection

48. Editorial Commentary: Protease Inhibitor Monotherapy: Safe for the CNS in Durably Suppressed Patients?

49. The Cerebrospinal Fluid HIV Risk Score for Assessing Central Nervous System Activity in Persons With HIV

50. The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment

Catalog

Books, media, physical & digital resources